Based on published evidence, semaglutide is the far more effective choice for fat loss, and AOD-9604 is now FDA-restricted (Category 2 bulk drug substance) for US compounding
5-Amino-1MQ supports AMPK activation and mitochondrial integrity, helping you maintain muscle while shedding fat
Pool of Seven Controlled Clinical Trials Adverse reactions were also evaluated in a larger pool of adult patients with type 2 diabetes mellitus participating in seven controlled clinical trials which included two placebo-controlled trials (SURPASS-1 and -5), three trials of MOUNJARO in combination with metformin, sulfonylureas, and/or SGLT2 Inhibitors (SURPASS-2, -3, -4) [see Clinical Studies (14.3)] and two additional trials conducted in Japan
Adults generally require around 1.5 micrograms per day and pregnant or breastfeeding women require up to 2.8 micrograms a day
Serious but less common risks may include: hypersensitivity reactions, hypokalemia (rare, with B12 correction of severe deficiency), and exacerbation of polycythemia
